SVIL and urinary bladder carcinoma: Then we overexpressed or silenced SVIL‐AS1 in MCF‐10A AKT1E17K, IHH4 (papillary thyroid carcinoma cell), and KU‐19‐19 (bladder carcinoma cell), which all had the AKT1E17K mutation (Figure 2C,F).